Found: 15
Select item for more details and to access through your institution.
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1253, doi. 10.1007/s40121-024-00970-x
- By:
- Publication type:
- Article
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 521, doi. 10.1007/s40121-024-00931-4
- By:
- Publication type:
- Article
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 9, p. 2269, doi. 10.1007/s40121-023-00861-7
- By:
- Publication type:
- Article
Validation of the standardised assessment of personality - abbreviated scale in a general population sample.
- Published in:
- Personality & Mental Health, 2015, v. 9, n. 4, p. 250, doi. 10.1002/pmh.1307
- By:
- Publication type:
- Article
The effect of carbon and nutrient loading during nursery culture on the growth of black spruce seedlings: a six-year field study.
- Published in:
- New Forests, 2007, v. 34, n. 3, p. 307, doi. 10.1007/s11056-007-9053-8
- By:
- Publication type:
- Article
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09117-w
- By:
- Publication type:
- Article
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomised controlled trial.
- Published in:
- Arthritis Research & Therapy, 2014, v. 16, n. 1, p. 1, doi. 10.1186/ar4439
- By:
- Publication type:
- Article
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.
- Published in:
- FASEB Journal, 2017, v. 31, n. 2, p. 526, doi. 10.1096/fj.201600860R
- By:
- Publication type:
- Article
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 7, p. 1247, doi. 10.1093/cid/ciac899
- By:
- Publication type:
- Article
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and in vitroIC<sub>50</sub> values predict SARS‐CoV‐2 neutralising antibody titres.
- Published in:
- Clinical & Translational Immunology, 2024, v. 13, n. 6, p. 1, doi. 10.1002/cti2.1517
- By:
- Publication type:
- Article
Predicting the Risk of Rheumatoid Arthritis and Its Age of Onset through Modelling Genetic Risk Variants with Smoking.
- Published in:
- PLoS Genetics, 2013, v. 9, n. 9, p. 1, doi. 10.1371/journal.pgen.1003808
- By:
- Publication type:
- Article
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 318, doi. 10.1634/theoncologist.2013-0282
- By:
- Publication type:
- Article
Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 10, p. 1153, doi. 10.1093/infdis/jiad014
- By:
- Publication type:
- Article
RNASeq_similarity_matrix: visually identify sample mix-ups in RNASeq data using a 'genomic' sequence similarity matrix.
- Published in:
- Bioinformatics, 2020, v. 36, n. 6, p. 1940, doi. 10.1093/bioinformatics/btz821
- By:
- Publication type:
- Article